Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 28-02-2014 | Practice Area: | Corporate and M&A |
| Deal Title: | R-Pharm Group Acquisition of Pfizer Production Plant | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
International law firm Simmons and Simmons advised Russian R-Pharm group on the acquisition of a production plant from Pfizer as well as a cooperation agreement.
The plant acquired by R-Pharm is located in the Bavarian town of Illertissen. The plant is producing Campix, a medication used to treat nicotine addiction which is now produced by R-Pharm for Pfizer.
R-Pharm group is a Russian life sciences company with 3,000 employees and an annual turnover of approximately USD2bn. With the acquisition of the Pfizer plant in Illertissen, R-Phram is taking further steps in its internationalisation strategy.
The team from Simmons and Simmons consisted of Corporate partners Boris Schilmar and Michael Bormann, Corporate counsel Vanessa Nieporte, Employment partner Verena Braeckeler-Kogel and Life Sciences regulatory specialist Associate Susanne Valluet.
|
||
| Financial Center: | Munich | Value: | 0.00-0.00 |
| Advised Party: | Acquiror | Law Firm | Simmons & Simmons |
| Target Company Jurisdiction: | Germany | Acquiror Jurisdiction: | Germany |
| Classification: |
Strategic Buyer Acquisitions Asset Sales |
Lawyer | Boris Schilmar |
